These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2563211

  • 1. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
    Douyon R, Angrist B, Peselow E, Cooper T, Rotrosen J.
    Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia.
    Barbee JG, Mancuso DM, Freed CR, Todorov AA.
    Am J Psychiatry; 1992 Apr; 149(4):506-10. PubMed ID: 1348161
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance.
    Altamura AC.
    Schizophr Res; 1993 Jan; 8(3):187-98. PubMed ID: 8094628
    [Abstract] [Full Text] [Related]

  • 9. Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes.
    Krakowski M, Czobor P, Volavka J.
    Psychiatry Res; 1997 Jun 16; 71(1):19-26. PubMed ID: 9247978
    [Abstract] [Full Text] [Related]

  • 10. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G, Annable L, Ross-Chouinard A.
    Am J Psychiatry; 1982 Mar 16; 139(3):312-8. PubMed ID: 6120655
    [No Abstract] [Full Text] [Related]

  • 11. [Neuroleptic modification of basic schizophrenic disorders].
    Heim M, Morgner J.
    Psychiatr Neurol Med Psychol (Leipz); 1987 May 16; 39(5):274-80. PubMed ID: 2888144
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
    Soni SD, Sampath G, Shah A, Krska J.
    Acta Psychiatr Scand; 1992 May 16; 85(5):354-9. PubMed ID: 1351333
    [Abstract] [Full Text] [Related]

  • 17. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug 16; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.
    Pecknold JC.
    J Psychiatry Neurosci; 1993 Mar 16; 18(2):82-4. PubMed ID: 8096393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.